林宇龙; 柯剑娟; 姚帆; 李才顺; 王言武
June 2016
Progress in Modern Biomedicine;Jun2016, Vol. 16 Issue 18, p3469
Academic Journal
Objective: To research the influence of rocuronium pharmacodynamics in patients with different degree of hepatosis.Methods: The 152 cases of patients with surgery were divided into three groups according to the Child-Pugh scores: group A(Child-Pugh A) with 62 cases, group B(Child-Pugh B) with 55 cases and group C(Child-Pugh C) with 35 cases. Meanwhile, 60 patients with normal liver function were included in this research as control group. Vecuronium bromide was injected with dynamic target control infusion procedure control, between 0.15~0.2 μg/m L, muscle relaxant T1/TC level maintained within 25%. General indexes including gender,age, weight and BMI, and the anesthesia onset time, maximum block anesthesia duration, T110% recovery time, T125% recovery time,T1 75 % recovery time, recovery index were analyzed and compared. Results: Anesthetic onset time extended gradually in A, B, C groups, and differences between them were statistically significant(P>0.05). The duration of block anesthesia in A, B, C groups gradually declined, and difference between them was statistically significant(P>0.05). Anesthesia recovery index in A, B, C groups increased gradually, and the difference between groups was statistically significant(P>0.05). T110 %, T125%, and T175 % % recovery time in group A, B, C, and the control group had no significant difference(P>0.05). In Child-Pugh class A group, the anesthesia onset time was obviously faster in women subgroup than in men subgroup, with statistically significant difference(P>0.05); and the block duration was longer in women subgroup than in men subgroup, also with statistically significant difference(P>0.05). In the Child-Pugh class B group, the anesthesia onset time was obviously faster in women subgroup than in men subgroup, and the difference was statistically significant(P>0.05). Yet, there were no statistical differences in onset time, maximum block anesthesia and recovery index between women and men in Child-Pugh C group(P>0.05). Conclusions: Hepatosis significantly affect the effect time of rocuronium. It could not consider the effect of gender when rocuronium is used for patients with severe liver disorders.


Related Articles

  • Pharmacokinetic–pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery. Fernández-Candil, Juan; Gambús, Pedro L.; Trocóniz, Iñaki F.; Valero, Ricard; Carrero, Enrique; Bueno, Lorea; Fábregas, Neus // European Journal of Clinical Pharmacology;Aug2008, Vol. 64 Issue 8, p795 

    Antiepileptic drugs decrease the intensity of the effect of neuromuscular blocking agents. The objective of this study was to evaluate the influence of chronic phenytoin therapy (CPT) on the pharmacokinetics (PK) and pharmacodynamics (PD) of rocuronium. A total of 21 patients undergoing...

  • Development and potential clinical impairment of ultra-short-acting neuromuscular blocking agents†. Lien, C. A. // BJA: The British Journal of Anaesthesia;Dec2011 Supplement 1, Vol. 107, pi60 

    Developing a non-depolarizing neuromuscular blocking agent that, like succinylcholine, has a rapid onset and a short duration of effect remains a goal of ongoing research. While rocuronium fills a portion of this need, the large doses required for rapid intubation render it a much longer-acting...

  • Influence of Obstructive Jaundice on Pharmacodynamics of Rocuronium. Wang, Zhen-Meng; Zhang, Peng; Lin, Mi-Jia; Tan, Bo; Qiu, Hai-Bo; Yu, Wei-Feng // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:Anesthetics are variable in patients with obstructive jaundice. The minimum alveolar concentration awake of desflurane is reduced in patients with obstructive jaundice, while it has no effect on pharmacodynamics and pharmacokinetics of propofol. In this study, we investigated the...

  • The use of magnesium sulfate to potentiate effect of low doses of rocuronium: a randomized study. Marachkou, A. V.; Lipnitski, A. L. // Surgery News / Novosti Hirurgii;2013, Vol. 21 Issue 6, p98 

    Objectives. To investigate the effect of magnesium sulfate during the onset time of rocuronium action, making conditions for the trachea intubation and find out the effect duration of rocuronium (low doses). Methods. Thirty patients (aged of 18-70 yrs.) underwent the laparoscopic cholecystectomy...

  • Repeat dosing of rocuronium-sugammadex: unpredictable. Yoon-Hee Kim // Korean Journal of Anesthesiology;Jul2014, Vol. 67 Issue 1, p1 

    The article focuses on impacts of repeated dosing of rocuronium-sugammadex on health. Topics discussed include dependence of effects of reinjected rocuronium on free rocuronium's plasma concentration, a case study of a 21-year-old male suffering with post-tonsillectomy hemorrhage reported by...

  • Rocuronium for nonemergent intubation of term and preterm infants. Feltman, D. M.; Weiss, M. G.; Nicoski, P.; Sinacore, J. // Journal of Perinatology;Jan2011, Vol. 31 Issue 1, p38 

    Objective:The aim of this study was to analyze clinical characteristics of rocuronium as premedication for nonemergent intubation in infants.Study Design:Preterm infants requiring nonemergent intubation were randomized to receive atropine and fentanyl with or without rocuronium. Outcomes,...

  • Clinical Pharmacokinetics of the Newer Neuromuscular Blocking Drugs. Paul, D.; Atherton, L.; Hunter, J.M. // Clinical Pharmacokinetics;1999, Vol. 36 Issue 3, p169 

    The pharmacokinetics of 6 new neuromuscular blocking drugs are described. These are the aminosteroids pipecuronium bromide, rocuronium bromide and rapacuronium bromide (ORG-9487) and the benzylisoquinolinium diesters doxacurium chloride, mivacurium chloride and cisatracurium besilate. In healthy...

  • Vliv veku a pohlav� na farmakodynamick� vlastnosti rokuronia behem tot�ln� intraven�zn� anestezie -- prospektivn� studie. Milan, Adamus; Lum�r, Hrab�lek; Tom�, Wanek; Tom�, Gabrhel�k; Jana, Zapletalov� // Anaesthesiology & Intensive Medicine / Anesteziologie a Intenziv;Feb2012, Vol. 23 Issue 1, p21 

    Objective: To compare the pharmacodynamics of 0.6 mg � kg-1 rocuronium in young and older patients of both genders during total intravenous anaesthesia. Design: Clinical, observational, non-blinded study. Setting: Department of Anaesthesiology, University Hospital. Materials and methods:...

  • Influence of real-time Bayesian forecasting of pharmacokinetic parameters on the precision of a rocuronium target-controlled infusion. Motamed, Cyrus; Devys, Jean-Michel; Debaene, Bertrand; Billard, Valérie // European Journal of Clinical Pharmacology;Jul2012, Vol. 68 Issue 7, p1025 

    Introduction: Bayesian forecasting has been shown to improve the accuracy of pharmacokinetic/pharmacodynamic (PK/PD) models by adding measured values to a population model. It could be done in real time for neuromuscular blockers (NMB) using measured values of effect. This study was designed to...

  • Sugammadex -- A short review and clinical recommendations for the cardiac anesthesiologist. Hemmerling, Thomas M.; Zaouter, Cedrick; Geldner, Goetz; Nauheimer, Dirk // Annals of Cardiac Anaesthesia;Sep2010, Vol. 13 Issue 3, p206 

    This review outlines the basic pharmacodynamic and pharmacokinetic properties of sugammadex for the cardiac anesthesiologist. It describes the different clinical scenarios when sugammadex can be used during cardiac surgery and gives clinical recommendations. Sugammadex is a unique reversal drug...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics